Trial Profile
Regional gastrointestinal delivery of remogliflozin etabonate in humans
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Remogliflozin etabonate (Primary) ; Remogliflozin etabonate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 27 Aug 2013 New trial record